Thrombocytopenia as an Adverse Effect of Levetiracetam Therapy in a Child

Abstract

Levetiracetam is one of the newer anti-epileptic medications, which is now widely used in the treatment of childhood epilepsy. Thrombocytopenia is not a well-known adverse effect of this medication. There have only been two adult case reports describing this feature as an adverse effect of levetiracetam. We describe this feature in a child. A six and half-year-old boy developed symptomatic epilepsy secondary to cerebral venous sinus thrombosis. He was treated with levetiracetam. He made a good recovery from his primary illness, but five weeks after he started taking levetiracetam, he presented with thrombocytopenia requiring platelet transfusion. Extensive investigations for known causes of thrombocytopenia were negative. Withdrawal of levetiracetam led to the resolution of thrombocytopenia. Levetiracetam-induced thrombocytopenia is a rare, but significant adverse effect.

levetiracetam - thrombocytopenia - adverse effect - epilepsy - children

References

• 1 Abou-Khalil B. Levetiracetam in the treatment of epilepsy.  Neuropsychiatr Dis Treat. 2008;  4 507-523
• 2 Beran RG, Berkovic SF, Black AB. Efficacy and safety of levetiracetam 1 000–3 000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.  Epilepsy Res. 2005;  63 1-9
• 3 Kenney B, Stack G. Drug-induced thrombocytopenia.  Arch Pathol Lab Med. 2009;  133 309-314
• 4 Kimland E, Höjeberg B, von Euler M. Levetiracetam-induced thrombocytopenia.  Epilepsia. 2004;  45 877-878
• 5 Meschede A, Runge U, Sabolek M. Thrombocytopenia during levetiracetam therapy.  Epilepsy Res. 2008;  80 91-92

Notice

This article was changed according to the following erratum on: 10.09.2010

Erratum
Some of the authors' names of this article were incorrect. The names of the authors should be as follows: B. Peer Mohamed, P. Prabhakar

Correspondence